Technological Advances Leading the Future of Parkinson Care: Cheryl Kyinn, PA-C
Nexalin Initiates Q-Submission Process for Transcranial Alternating Current Stimulation Device in Alzheimer Studies
FDA Approves STS101 for Acute Migraine, CALLIPER Trial Results Unveiled, Nipocalimab Gains FDA Approval for Myasthenia Gravis
NeurologyLive® Friday 5 — May 2, 2025